The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.
Matthews
D C
DC
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Appelbaum
F R
FR
Press
O W
OW
Eary
J F
JF
Bernstein
I D
ID
D000906:Antibodies; D015703:Antigens, CD / Q000276:immunology; D015214:Antigens, Differentiation, Myelomonocytic / Q000276:immunology; D016026:Bone Marrow Transplantation / Q000379:methods*; D015815:Cell Adhesion Molecules / Q000276:immunology; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D019337:Hematologic Neoplasms / Q000628:therapy*; D006689:Hodgkin Disease / Q000628:therapy; D006801:Humans; D007553:Isotope Labeling; D017493:Leukocyte Common Antigens / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology; D016499:Radioimmunotherapy; D063268:Sialic Acid Binding Ig-like Lectin 3
D000906:Antibodies; D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; C571163:CD33 protein, human; D015815:Cell Adhesion Molecules; D008562:Membrane Glycoproteins; D063268:Sialic Acid Binding Ig-like Lectin 3; D017493:Leukocyte Common Antigens